申请人:Glaxo Group Limited
公开号:US10174053B2
公开(公告)日:2019-01-08
The compounds of the subject invention are related to 2-substituted cephem compounds, which have a wide antimicrobial spectrum, in particular exhibit potent antimicrobial activity against beta-lactamase producing Gram negative bacteria, and pharmaceutical compositions comprising the same.
本发明的化合物与 2-取代的头孢化合物有关,它们具有广泛的抗菌谱,特别是对β-内酰胺酶产生的革兰氏阴性菌具有强效抗菌活性,以及包含这些化合物的药物组合物。